American Academy of Neurology: Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease
September 19, 2024
September 19, 2024
MINNEAPOLIS, Minnesota, Sept. 19 (TNSres) -- The American Academy of Neurology issued the following news release on Sept. 18, 2024:
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology(R), the medical journal of the American Academy of Neurology.
The study looked at sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are also known a . . .
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology(R), the medical journal of the American Academy of Neurology.
The study looked at sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are also known a . . .